Individualizing Anticoagulant use in Older Adults with Atrial Fibrillation

Information

  • Research Project
  • 10339189
  • ApplicationId
    10339189
  • Core Project Number
    K76AG074919
  • Full Project Number
    1K76AG074919-01
  • Serial Number
    074919
  • FOA Number
    RFA-AG-21-020
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 2 years ago
  • Project End Date
    8/31/2026 - 2 years from now
  • Program Officer Name
    ZIEMAN, SUSAN
  • Budget Start Date
    9/30/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/23/2021 - 2 years ago
Organizations

Individualizing Anticoagulant use in Older Adults with Atrial Fibrillation

Project Summary/Abstract This is a Beeson (K76) career development award for Sachin J Shah, MD, MPH, a physician-investigator trained in internal medicine, clinical epidemiology, and aging research. Dr. Shah is an Assistant Professor in the Division of Hospital Medicine at the University of California, San Francisco. Dr. Shah's long-term goal is to build evidence to individualize treatment recommendations for older adults facing high-risk, high-benefit therapeutic decisions using new epidemiologic methods and geriatric research principles. The decision to use anticoagulants in older adults with atrial fibrillation (AF) is the paradigm of a high-stakes therapeutic decision because while anticoagulants prevent stroke, they increase the risk of bleeding complications. Guidelines use a one-size-fits-all approach; for older adults, they recommend near-universal anticoagulant use. In numerous studies of clinical practice, physicians report concern with the current approach voicing the need to individualize treatment recommendations for older adults. This proposal addresses the pressing need to individualize anticoagulant treatment decisions in older adults with AF through two aims. Aim 1: Develop and validate individualized estimates of the treatment effect of anticoagulants for ischemic stroke prevention in older adults with AF. This aim will use clinical trial and observational data to develop and validate a treatment effect model that will estimate individual-level treatment benefit. Aim 2: Ascertain functional outcomes after major extracranial hemorrhage, both short-term and longer-term. The functional outcomes following major hemorrhage, a key adverse event of anticoagulant therapy, are unclear, especially in older adults. Through two studies, this proposal will determine the short- and long-term functional outcomes following major hemorrhage. Dr. Shah's exceptional, multidisciplinary mentoring team is led by Dr. Margaret Fang, nationally recognized for her work studying the clinical outcomes of anticoagulants in older adults and co-mentored by Dr. Kenneth Covinsky, whose nationally recognized research program has advanced our understanding of the predictors and outcomes of disability in older adults. This career development award will support Dr. Shah's transition to research independence through mentorship and focused training in (1) measuring heterogeneous treatment effects using novel epidemiologic tools, (2) primary data collection to build prospective cohorts of older adults, (3) designing decision aids and (4) leadership development to lead cross-disciplinary, multi-institutional research teams. This proposal will support a development grant to design and pilot a clinical decision tool for older adults considering anticoagulant and a project grant to measure heterogeneous treatment effects of procedural interventions in older adults with AF. The proposed research and training aims will provide Dr. Shah with the data, training, and experience to support competitive R-series applications.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    K76
  • Administering IC
    AG
  • Application Type
    1
  • Direct Cost Amount
    225000
  • Indirect Cost Amount
    18000
  • Total Cost
    243000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    866
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIA:243000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZAG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • Organization Department
    PATHOLOGY
  • Organization DUNS
    094878337
  • Organization City
    SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    941430962
  • Organization District
    UNITED STATES